A Study of Ivonescimab in People With Non-Small Cell Lung Cancer

Full Title

Phase II Study of Ivonescimab Consolidation after Photon or Proton SBRT for Patients with Early-Stage NSCLC (I-PRECISE)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Narek Shaverdian’s office at 631-212-6323.

Protocol
26-063
Phase
Phase I/II (phases 1 and 2 combined)
Investigator
Narek Shaverdian
Co-Investigators
Jamie E. Chaft
Charles B. Simone
Diseases
Lung Cancer › Lung Cancer, Non-Small Cell
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07594522
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description